GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Total Payout Yield %

G.Barekat Pharm (XTEH:BRKT1) Total Payout Yield % : 0.00 (As of May. 16, 2024)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

G.Barekat Pharm's current Total Payout Yield % is 0.00%.


G.Barekat Pharm Total Payout Yield % Historical Data

The historical data trend for G.Barekat Pharm's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Total Payout Yield % Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Total Payout Yield %
- -

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Total Payout Yield % - -

Competitive Comparison of G.Barekat Pharm's Total Payout Yield %

For the Biotechnology subindustry, G.Barekat Pharm's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G.Barekat Pharm's Total Payout Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Total Payout Yield % falls into.



G.Barekat Pharm Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

G.Barekat Pharm's Total Payout Yield % for the fiscal year that ended in Mar. 2017 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (0 + 0 + 0) / 6602817.0726
=0.00%

G.Barekat Pharm's annualized Total Payout Yield % for the quarter that ended in Mar. 2017 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 0 + 0) * 1 / 6602817.0726
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G.Barekat Pharm Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


G.Barekat Pharm Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines